| IV-22 Bruno Bieth Use of population PK/PD modeling to support the regulatory approval of canakinumab as first biologic treatment in patients with periodic fever syndromes Thursday 14:45-16:15 |
| IV-22 Bruno Bieth Use of population PK/PD modeling to support the regulatory approval of canakinumab as first biologic treatment in patients with periodic fever syndromes Thursday 14:45-16:15 |